Emerging drugs for ichthyosis
- 5 November 2007
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Emerging Drugs
- Vol. 12 (4) , 647-656
Abstract
The ichthyoses constitute a large and heterogeneous group of disorders characterised by varying degrees of skin scaling. Most forms are rare but between them, they affect tens of thousands of people worldwide. Treatment presently consists primarily of topical keratolytic agents, aimed at removing the ichthyotic scales, and emollients. If an ichthyosis cannot be controlled by topical therapy alone, retinoids can be used. Although effective in several forms of ichthyosis, side effects and teratogenicity severely limit their use. The recent development of retinoic acid metabolism blocking agents (RAMBAs) offers new possibilities. With these drugs, retinoid effects may be obtained with less side effects and a shorter post-treatment teratogenicity period. This review discusses the RAMBAs that are now in clinical trials and outlines possible future developments.Keywords
This publication has 44 references indexed in Scilit:
- Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczemaNature Genetics, 2007
- Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizationsJournal of Allergy and Clinical Immunology, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- Mutations in ABCA12 Underlie the Severe Congenital Skin Disease Harlequin IchthyosisThe American Journal of Human Genetics, 2005
- Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosisHuman Molecular Genetics, 2004
- Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2Human Molecular Genetics, 2003
- Cholesterol 3-Sulfate Interferes with Cornified Envelope Assembly by Diverting Transglutaminase 1 Activity from the Formation of Cross-links and Esters to the Hydrolysis of GlutamineJournal of Biological Chemistry, 2000
- Recessive x-Linked Ichthyosis: Role of Cholesterol-Sulfate Accumulation in the Barrier AbnormalityJournal of Investigative Dermatology, 1998
- Cholesterol Sulfate Inhibits Proteases that are Involved in Desquamation of Stratum CorneumJournal of Investigative Dermatology, 1998
- The Proteins Elafin, Filaggrin, Keratin Intermediate Filaments, Loricrin, and Small Proline-rich Proteins 1 and 2 Are Isodipeptide Cross-linked Components of the Human Epidermal Cornified Cell EnvelopeJournal of Biological Chemistry, 1995